October 23, 2019

MaxQ AI Joins Nuance AI Marketplace for Diagnostic Imaging

Via AI Authority by AIT Newsdesk October 23, 2019

MaxQ AI, the industry-leading medical diagnostic AI company, announced that its Accipio Ix and Accipio Ax intracranial hemorrhage (ICH) detection software will be available on the Nuance AI Marketplace, the first and largest portal with one-stop access to a wide range of AI diagnostic models from within the industry’s most widely used radiology reporting platform.

MaxQ AI’s ACCIPIO ICH and Stroke Platform utilizes deep learning technologies to analyze medical imaging data such as non-contrast head CT images. The results provide deep clinical insight and actionable data in minutes that will enable physicians across the world to make faster assessments of stroke, traumatic brain injury, and head trauma in any location, at any time. Accipio Ix enables automatic identification and prioritization of non-contrast head CT images with suspected ICH. Accipio Ax provides automatic slice-level annotation of suspected ICH. Both Accipio Ix and Ax are FDA Cleared and CE Approved.